Expansion of (CTG)•(CAG) trinucleotide repeat (TNR) microsatellite sequences is responsible for at least a dozen neuromuscular and neurodegenerative diseases, including Huntington's disease and ...
CTG's revenue decreased by 4.9% year-over-year to $71.3 million in Q3 2023. Gross margin improved significantly by 300 basis points from the prior year to 27.3%. The company reported a net loss of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results